1-20 of 440 Search Results for

hypercalcemia

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491038
EISBN: 978-3-318-06409-4
... Abstract Familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) are genetically determined variants of primary hyperparathyroidism. FHH usually has a benign course, and patients do not require treatment, whereas NSHPT is a severe disorder often requiring...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491040
EISBN: 978-3-318-06409-4
... Abstract Primary hyperparathyroidism is among the most common causes of hypercalcemia. However, ingestion of medication, including hydrochlorathiazide, lithium, and foscarnet, excessive vitamin A ingestion, endocrinopathies such as hyperthyroidism, adrenal insufficiency, and acromegaly...
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491034
EISBN: 978-3-318-06409-4
... concentrations. Hypercalcemia may be distinguished in parathyroid-hypercalcemia and nonparathyroid hypercalcemia. The most common disorders include primary hyperparathyroidism (PHPT), malignancy, granulomatous diseases, and medications. PHPT is a disease characterized by excessive secretion of PTH. PHPT is most...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
EISBN: 978-3-318-06409-4
.... Wu B, Wang O, Jiang Y, Li M, Xing X, Xia W: Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient. Bone Res 2017;5:17001. 3. Marx SJ: Calcimimetic use in familial hypocalciuric hypercalcemia - a perspective in endocrinology. J Clin Endocrinol Metab 2017;102...
Book Chapter
Series: Endocrine Development
Volume: 28
Published: 11 June 2015
EISBN: 978-3-318-05467-5
...References References 1. Davies JH, Shaw NJ: Investigation and management of hypercalcaemia in children. Arch Dis Child 2012;97:533-538. 2. Koltin D, Rachmiel M, Wong BY, Cole DE, Harvey E, Sochett E: Mild infantile hypercalcemia: diagnostic tests and outcomes. J Pediatr 2011;159:215-221...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
EISBN: 978-3-318-06409-4
... and calcium levels: a retrospective longitudinal naturalistic study. Neuropsychiatr Dis Treat 2015;11:1785-1791. 3. Nussbaum SR, Gaz RD, Arnold A: Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for PTH. N Engl J Med 1990;323:1324-1328...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 50
Published: 20 April 2018
10.1159/000486073
EISBN: 978-3-318-06339-4
... genetic defects of (a) CYP24A1, the chief enzyme for the degradation of 1,25-(OH) 2 D 3 and (b) the sodium/phosphate co-transporter 2A. We update the reader on the mechanisms underlying hypervitaminosis D caused by excessive vitamin D intakes and the hypercalcemia of granulomatous diseases...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
EISBN: 978-3-318-06409-4
..., Marcus R, Levine MA, Marcocci C, Silverberg SJ, Potts JT Jr (eds): The Parathyroids, ed 3. Cambridge, Academic Press, 2015, pp 309-314. 6. Bilezikian JP, Bandeira L, Khan A, Cusano NE: Hyperparathyroidism. Lancet 2018;391:168-178. 7. Horwitz MJ, Hodak SP, Stewart AF: Non-parathyroid hypercalcemia...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 50
Published: 20 April 2018
EISBN: 978-3-318-06339-4
..., Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Akcay T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M: Mutations of CYP24A1 and Idiopathic Infantile Hypercalcemia. N Engl J Med 2011;365:410-421. 26. St-Arnaud R, Naja RP: Vitamin D metabolism, cartilage and bone fracture repair. Mol...
Book
Book Cover Image
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/isbn.978-3-318-06409-4
EISBN: 978-3-318-06409-4
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491036
EISBN: 978-3-318-06409-4
... primary hyperparathyroidism (PHPT) associated with persistent normal serum calcium levels, which has been recognized as a distinct entity from hypercalcemic PHPT (HPHPT) by the last international consensus. Normocalcemic PHPT (NPHPT) affects about 6-8% of PHPT patients. Although hypercalcemia is absent...
Book Chapter
Published: 17 August 2012
10.1159/000336424
EISBN: 978-3-8055-9930-6
... with hypercalcemia or hypocalcemia. The common conditions primary hyperparathyroidism, lithium-induced hypercalcemia, and osteomalacia, all with a strong impact in females, are reviewed. Osteoporosis with bone fragility and fractures is increasing worldwide. Women start fracturing at an earlier age than men...
Book Chapter
Series: Endocrine Development
Volume: 28
Published: 11 June 2015
10.1159/000380998
EISBN: 978-3-318-05467-5
.... Arch Dis Child 2012;97:533-538. 2. Koltin D, Rachmiel M, Wong BY, Cole DE, Harvey E, Sochett E: Mild infantile hypercalcemia: diagnostic tests and outcomes. J Pediatr 2011;159:215-221.e1. 3. Hind E, Wood P, Walker V, Davies JH: The investigation of hypercalcaemia in children and adolescents...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491039
EISBN: 978-3-318-06409-4
... treatment of hypercalcemia has a pivotal role in the management of these patients. Parathyroid carcinoma (PC) is a rare endocrine neoplasm accounting for approximately 0.005% of all malignancies in North America and most western countries, and less than 1% of all cases of sporadic primary...
Book Chapter
Series: Contributions to Nephrology
Volume: 199
Published: 17 December 2021
10.1159/000517695
EISBN: 978-3-318-06937-2
... ]. In general, the treatment strategy of hyponatremia in oncological patients is not different from that suggested by the available recommendations (Table 2 ). Table 2. Therapy schemes for principal metabolic and electrolyte disorders in cancer patients Hypercalcemia Malignancy-associated...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 51
Published: 04 December 2018
10.1159/000491037
EISBN: 978-3-318-06409-4
... been identified. They include multiple endocrine neoplasia (MEN; types 1, 2A, and 4), hyperparathyroidism-jaw tumor (HPT-JT) syndrome, familial isolated hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH), and neonatal severe PHPT. Each MEN type is associated with the various combinations...